There are 2789 resources available
1031TiP - Vascular intervention combined with camrelizumab and apatinib for patients with inoperable solid tumors: An exploratory study
Presenter: Feng Gao
Session: ePoster Display
1033TiP - A first-in-human phase I study of FS120, an OX40/CD137 tetravalent bispecific antibody, in patients with advanced malignancies
Presenter: Kyriakos Papadopoulos
Session: ePoster Display
1034TiP - ARTISTRY-6: Nemvaleukin alfa monotherapy in patients with advanced mucosal and cutaneous melanoma
Presenter: Richard Carvajal
Session: ePoster Display
1707P - A single G-CSF administration is enough to limit neutropenia in patients treated by eribulin
Presenter: Antonin Schmitt
Session: ePoster Display
1708P - Severe neutropenia (grade 4, Gr4N) as a population-based predictor for adverse clinical outcome of chemotherapy induced neutropenia (CIN)
Presenter: Ramon Mohanlal
Session: ePoster Display
1709P - Prediction of febrile neutropenia (FN), hospitalization (Hosp) rates, and infection (Inf) rates in chemotherapy-induced neutropenia (CIN) patients (pts) treated with the plinabulin and pegfilgrastim combination (Plin+Peg) using a meta-analysis (MA)-based tool
Presenter: Stephan Ogenstad
Session: ePoster Display
1710P - Impact of adding plinabulin to pegfilgrastim for the prevention of chemotherapy induced neutropenia (CIN) on patient quality of life (QoL)
Presenter: Douglas Blayney
Session: ePoster Display
1711P - Real-world study of mecapegfilgrastim in preventing neutropenia in patients with gastrointestinal tumors
Presenter: Nong Xu
Session: ePoster Display
1712P - Safety and efficacy of influenza and pneumococcal vaccines in cancer patients on active therapy: A prospective study
Presenter: Nicla Maria La Verde
Session: ePoster Display